Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis

被引:213
作者
Zabner, J
Ramsey, BW
Meeker, DP
Aitken, ML
Balfour, RP
Gibson, RL
Launspach, J
Moscicki, RA
Richards, SM
Standaert, TA
WilliamsWarren, J
Wadsworth, SC
Smith, AE
Welsh, MJ
机构
[1] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT INTERNAL MED,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242
[3] UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98105
[4] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98105
[5] UNIV WASHINGTON,MED CTR,SEATTLE,WA 98105
[6] GENZYME CORP,FRAMINGHAM,MA 01701
关键词
gene transfer; airway; immune response; chloride; ion channel;
D O I
10.1172/JCI118573
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cystic fibrosis (CF) is a common autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator gene, Recombinant adenoviruses have shown promise as vectors for transfer of CF transmembrane conductance regulator cDNA to airway epithelia and correction of the Cl- transport defect, However, because adenovirus-mediated gene transfer is transient, use of adenovirus as a vector for treatment of CF would require repeated administration. Therefore, we evaluated repeat administration of an adenovirus vector to the nasal epithelium of patients with CF with five escalating doses of up to 10(10) infectious units, There were no detectable adverse affects, All subjects were initially seropositive but developed additional humoral immune responses. The vector partially corrected the defect in airway epithelial Cl- transport in some subjects, although there was variability between subjects and there was less correction with subsequent administration, perhaps because the immune response limited gene transfer, Future work must focus on vectors with increased efficiency and with the ability to evade host defenses.
引用
收藏
页码:1504 / 1511
页数:8
相关论文
共 32 条
[1]   MEASUREMENT OF NASAL POTENTIAL DIFFERENCE IN ADULT CYSTIC-FIBROSIS, YOUNGS SYNDROME, AND BRONCHIECTASIS [J].
ALTON, EWFW ;
HAY, JG ;
MUNRO, C ;
GEDDES, DM .
THORAX, 1987, 42 (10) :815-817
[2]  
ARMENTANO D, 1995, IN PRESS HUM GENE TH
[3]  
BOUT A, 1994, GENE THER, V1, P385
[4]   ACUTE RESPONSES OF NONHUMAN-PRIMATES TO AIRWAY DELIVERY OF AN ADENOVIRUS VECTOR CONTAINING THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA [J].
BRODY, SL ;
METZGER, M ;
DANEL, C ;
ROSENFELD, MA ;
CRYSTAL, RG .
HUMAN GENE THERAPY, 1994, 5 (07) :821-836
[5]   CYSTIC-FIBROSIS - MOLECULAR-BIOLOGY AND THERAPEUTIC IMPLICATIONS [J].
COLLINS, FS .
SCIENCE, 1992, 256 (5058) :774-779
[6]   ADMINISTRATION OF AN ADENOVIRUS CONTAINING THE HUMAN CFTR CDNA TO THE RESPIRATORY-TRACT OF INDIVIDUALS WITH CYSTIC-FIBROSIS [J].
CRYSTAL, RG ;
MCELVANEY, NG ;
ROSENFELD, MA ;
CHU, CS ;
MASTRANGELI, A ;
HAY, JG ;
BRODY, SL ;
JAFFE, HA ;
EISSA, NT ;
DANEL, C .
NATURE GENETICS, 1994, 8 (01) :42-51
[7]   DIRECT GENE-TRANSFER OF HUMAN CFTR INTO HUMAN BRONCHIAL EPITHELIA OF XENOGRAFTS WITH E1-DELETED ADENOVIRUSES [J].
ENGELHARDT, JF ;
YANG, YP ;
STRATFORDPERRICAUDET, LD ;
ALLEN, ED ;
KOZARSKY, K ;
PERRICAUDET, M ;
YANKASKAS, JR ;
WILSON, JM .
NATURE GENETICS, 1993, 4 (01) :27-34
[8]   INEFFICIENT GENE-TRANSFER BY ADENOVIRUS VECTOR TO CYSTIC-FIBROSIS AIRWAY EPITHELIA OF MICE AND HUMANS [J].
GRUBB, BR ;
PICKLES, RJ ;
YE, H ;
YANKASKAS, JR ;
VICK, RN ;
ENGELHARDT, JF ;
WILSON, JM ;
JOHNSON, LG ;
BOUCHER, RC .
NATURE, 1994, 371 (6500) :802-806
[9]   MODIFICATION OF NASAL EPITHELIAL POTENTIAL DIFFERENCES OF INDIVIDUALS WITH CYSTIC-FIBROSIS CONSEQUENT TO LOCAL-ADMINISTRATION OF A NORMAL CFTR CDNA ADENOVIRUS GENE-TRANSFER VECTOR [J].
HAY, JG ;
MCELVANEY, NG ;
HERENA, J ;
CRYSTAL, RG .
HUMAN GENE THERAPY, 1995, 6 (11) :1487-1496
[10]  
INGELS KJAO, 1994, ARCH OTOLARYNGOL, V120, P197